Clinical Trials Browser

Phase 2 × Radiation Therapy × Axitinib × Clear all

NCT06889649 2025-03-21

SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC

Phase 2 Recruiting

Radiation Therapy